Key Takeaways
- • Point72 Asset Management returned just 1.2% in the first half of 2021, significantly underperforming comparable multi-strategy hedge funds including Citadel (up 4.4%) and Millennium Management (up 6.5%).
- • Steve Cohen's $22 billion hedge fund was weighed down in part by its $750 million investment in Melvin Capital, the fund run by Cohen's former star trader Gabe Plotkin.
- • The underperformance reflects the challenges facing Point72 as it manages a substantial capital base while dealing with concentrated losses in a major portfolio position.
Summary
Steve Cohen's Point72 Asset Management significantly trailed its hedge fund peers during the first half of 2021, delivering a modest 1.2% return on the $22 billion fund. This performance gap stands in sharp contrast to other large multi-strategy competitors: Citadel generated a 4.4% return while Millennium Management achieved 6.5% gains during the same period.
The underperformance was attributed in part to Cohen's $750 million investment in Melvin Capital, the hedge fund founded by Gabe Plotkin, one of Cohen's former top traders. This bet on Melvin represented a significant capital allocation that ultimately dragged on Point72's overall returns during a period when the broader hedge fund industry demonstrated more robust performance.
The investment in Melvin Capital came after the fund suffered substantial losses, with both Cohen's Point72 and rival firm Citadel (which contributed $2 billion) providing capital infusions to stabilize the operation. For Point72, the decision to back Plotkin's fund—made during a period of market stress—proved to be a challenging capital deployment that weighed on the firm's first-half results and highlighted the risks of concentrated bets even for well-established managers operating multi-strategy platforms.
The underperformance was attributed in part to Cohen's $750 million investment in Melvin Capital, the hedge fund founded by Gabe Plotkin, one of Cohen's former top traders. This bet on Melvin represented a significant capital allocation that ultimately dragged on Point72's overall returns during a period when the broader hedge fund industry demonstrated more robust performance.
The investment in Melvin Capital came after the fund suffered substantial losses, with both Cohen's Point72 and rival firm Citadel (which contributed $2 billion) providing capital infusions to stabilize the operation. For Point72, the decision to back Plotkin's fund—made during a period of market stress—proved to be a challenging capital deployment that weighed on the firm's first-half results and highlighted the risks of concentrated bets even for well-established managers operating multi-strategy platforms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.